Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort.

Bakhuizen JJ, Hogervorst FB, Velthuizen ME, Ruijs MW, van Engelen K, van Os TA, Gille JJ, Collée M, van den Ouweland AM, van Asperen CJ, Kets CM, Mensenkamp AR, Leter EM, Blok MJ, de Jong MM, Ausems MG.

Fam Cancer. 2019 Jan 3. doi: 10.1007/s10689-018-00118-0. [Epub ahead of print]

PMID:
30607672
2.

Identifying patients with a history of ovarian cancer for referral for genetic counselling: non-randomised comparison of two case-finding strategies in primary care.

Helsper CW, Van Vliet LM, Velthuizen ME, de Wit NJ, Beijaert RP, Butter E, van Gent-Wagemakers MP, Witteveen EO, Zweemer RP, van Dulmen SM, Ausems MG.

Br J Gen Pract. 2018 Nov;68(676):e750-e756. doi: 10.3399/bjgp18X699533.

3.

Genetic counselling of young women with breast cancer for Li-Fraumeni syndrome: a nationwide survey on the experiences and attitudes of genetics professionals.

Bakhuizen JJ, Velthuizen ME, Stehouwer S, Bleiker EM, Ausems MG.

Fam Cancer. 2018 Sep 20. doi: 10.1007/s10689-018-0103-5. [Epub ahead of print]

PMID:
30238178
4.

Referral to cancer genetic counseling: do migrant status and patients' educational background matter?

van der Giessen JAM, van Riel E, Velthuizen ME, van Dulmen AM, Ausems MGEM.

J Community Genet. 2017 Oct;8(4):303-310. doi: 10.1007/s12687-017-0326-4. Epub 2017 Sep 4.

5.

Breast cancer genetic counseling among Dutch patients from Turkish and Moroccan descent: participation determinants and perspectives of patients and healthcare professionals.

Baars JE, van Dulmen AM, Velthuizen ME, van Riel E, Ausems MG.

J Community Genet. 2017 Apr;8(2):97-108. doi: 10.1007/s12687-016-0290-4. Epub 2017 Jan 12.

6.

Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?

van Tilborg TC, Derks-Smeets IA, Bos AM, Oosterwijk JC, van Golde RJ, de Die-Smulders CE, van der Kolk LE, van Zelst-Stams WA, Velthuizen ME, Hoek A, Eijkemans MJ, Laven JS, Ausems MG, Broekmans FJ.

Hum Reprod. 2016 Nov;31(11):2651-2659. Epub 2016 Oct 5.

PMID:
27907901
7.

Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry.

Vasen HF, Velthuizen ME, Kleibeuker JH, Menko FH, Nagengast FM, Cats A, van der Meulen-de Jong AE, Breuning MH, Roukema AJ, van Leeuwen-Cornelisse I, de Vos Tot Nederveen Cappel WH, Wijnen JT.

Fam Cancer. 2016 Jul;15(3):429-35. doi: 10.1007/s10689-016-9897-1.

8.

Migrant breast cancer patients and their participation in genetic counseling: results from a registry-based study.

Baars JE, van Dulmen AM, Velthuizen ME, Theunissen EB, Vrouenraets BC, Kimmings AN, van Dalen T, van Ooijen B, Witkamp AJ, van der Aa MA, Ausems MG.

Fam Cancer. 2016 Apr;15(2):163-71. doi: 10.1007/s10689-016-9871-y.

9.

Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.

ten Broeke SW, Brohet RM, Tops CM, van der Klift HM, Velthuizen ME, Bernstein I, Capellá Munar G, Gomez Garcia E, Hoogerbrugge N, Letteboer TG, Menko FH, Lindblom A, Mensenkamp AR, Moller P, van Os TA, Rahner N, Redeker BJ, Sijmons RH, Spruijt L, Suerink M, Vos YJ, Wagner A, Hes FJ, Vasen HF, Nielsen M, Wijnen JT.

J Clin Oncol. 2015 Feb 1;33(4):319-25. doi: 10.1200/JCO.2014.57.8088. Epub 2014 Dec 15.

PMID:
25512458
10.

Routine assessment of psychosocial problems after cancer genetic counseling: results from a randomized controlled trial.

Eijzenga W, Bleiker EM, Ausems MG, Sidharta GN, Van der Kolk LE, Velthuizen ME, Hahn DE, Aaronson NK.

Clin Genet. 2015 May;87(5):419-27. doi: 10.1111/cge.12473. Epub 2014 Oct 13.

PMID:
25130962
11.

Effect of routine assessment of specific psychosocial problems on personalized communication, counselors’ awareness, and distress levels in cancer genetic counseling practice: a randomized controlled trial.

Eijzenga W, Aaronson NK, Hahn DE, Sidharta GN, van der Kolk LE, Velthuizen ME, Ausems MG, Bleiker EM.

J Clin Oncol. 2014 Sep 20;32(27):2998-3004.

PMID:
25049325
12.

Active approach for breast cancer genetic counseling during radiotherapy: long-term psychosocial and medical impact.

Baars JE, Bleiker EM, van Riel E, Rodenhuis CC, Velthuizen ME, Schlich KJ, Ausems MG.

Clin Genet. 2014 Jun;85(6):524-31. doi: 10.1111/cge.12335. Epub 2014 Feb 4.

PMID:
24372530
13.

Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations.

Brohet RM, Velthuizen ME, Hogervorst FB, Meijers-Heijboer HE, Seynaeve C, Collée MJ, Verhoef S, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gómez García E, Menko F, Oosterwijk JC, Devilee P, van't Veer LJ, van Leeuwen FE, Easton DF, Rookus MA, Antoniou AC; HEBON Resource.

J Med Genet. 2014 Feb;51(2):98-107. doi: 10.1136/jmedgenet-2013-101974. Epub 2013 Nov 27.

PMID:
24285858

Supplemental Content

Loading ...
Support Center